Name (Synonyms) | Correlation | |
---|---|---|
drug867 | Ergoferon Wiki | 1.00 |
drug1822 | Placebo Wiki | 0.06 |
Name (Synonyms) | Correlation | |
---|---|---|
D014777 | Virus Diseases NIH | 0.12 |
D003141 | Communicable Diseases NIH | 0.09 |
D007239 | Infection NIH | 0.06 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
A retrospective case series of patients who self-medicated with Famotidine during coronavirus disease 2019 (COVID-19). The study will collect de-identified patient reported outcome measures of patients with confirmed COVID-19 who self-medicated with Famotidine at any dose during the period of illness. Data will be collected by questionnaire and telephone interview. Inclusion criteria: Age>18; Ability to give written informed consent for study participation; Confirmed diagnosis of COVID-19; Use of Famotidine at any dose during period of COVID-19 illness
Description: Symptoms assessed by severity scores on an ordinal scale; 1=not affected to 4= severely affected
Measure: Symptomatic improvement Time: 2 weeksDescription: Oxygen saturation determined by pulse oximetry
Measure: Peripheral blood oxygen saturation Time: 2 weeks